↓ Skip to main content

Trifluoperazine for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, January 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 tweeters
weibo
1 weibo user
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
104 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Trifluoperazine for schizophrenia
Published in
Cochrane database of systematic reviews, January 2004
DOI 10.1002/14651858.cd003545.pub2
Pubmed ID
Authors

Luciana de Oliveira Marques, Bernardo Soares, Mauricio Silva de Lima

Abstract

Trifluoperazine is an inexpensive accessible 'high potency' antipsychotic drug, widely used to treat schizophrenia or related psychoses.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 104 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 19%
Student > Bachelor 16 15%
Student > Doctoral Student 11 11%
Researcher 10 10%
Student > Ph. D. Student 7 7%
Other 19 18%
Unknown 21 20%
Readers by discipline Count As %
Medicine and Dentistry 30 29%
Psychology 16 15%
Nursing and Health Professions 12 12%
Social Sciences 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 12 12%
Unknown 26 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 March 2017.
All research outputs
#3,533,452
of 15,306,213 outputs
Outputs from Cochrane database of systematic reviews
#5,969
of 11,168 outputs
Outputs of similar age
#50,977
of 249,596 outputs
Outputs of similar age from Cochrane database of systematic reviews
#291
of 478 outputs
Altmetric has tracked 15,306,213 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,168 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.9. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 249,596 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 478 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.